IPHARMA is a contract research organization focusing on conducting clinical trials and the registration of investigational drugs and medical devices in Russia and EAEU. IPHARMA is a member of ChemRar High-Tech Center group of companies and an accredited partner of Skolkovo Innovation Center. Our pipeline consists of over 150 clinical trials in oncology, virology, endocrinology, pulmonology, neurology, transplantology, etc. We provide agile clinical services in both early-phase and registration trials, as well as medical, regulatory, and PV expertise to ensure an optimal timeline for your drug development. IPHARMA is a reliable partner and an ideal platform for the clinical development of new medicinal products and medical devices. According to the information-analytical bulletin issued by the Association of Clinical Trial Organizations (ACTO), IPHARMA topped the list of CROs by the number of local trials and bioequivalence trials conducted in 2020.